Cargando…

MicroRNA-503 serves an oncogenic role in laryngeal squamous cell carcinoma via targeting programmed cell death protein 4

Laryngeal squamous cell carcinoma (LSCC), the most common form of laryngeal carcinoma, is an aggressive malignancy that demonstrates the second highest rate of morbidity of all head and neck squamous cell carcinomas. The abnormal expression of microRNAs (miRs) has been demonstrated in a number of ty...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shuang, Yu, Zhou, Xuan, Li, Chao, Huang, Yongwang, Zhang, Lun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647079/ https://www.ncbi.nlm.nih.gov/pubmed/28849168 http://dx.doi.org/10.3892/mmr.2017.7278

Ejemplares similares

MicroRNA-195 inhibits growth and invasion of laryngeal carcinoma cells by directly targeting DCUN1D1
por: Shuang, Yu, et al.
Publicado: (2017)

Circular RNA MYLK serves as an oncogene to promote cancer progression via microRNA-195/cyclin D1 axis in laryngeal squamous cell carcinoma
por: Duan, Xiaohui, et al.
Publicado: (2019)

MicroRNA-503 and the Extended MicroRNA-16 Family in Angiogenesis
por: Caporali, Andrea, et al.
Publicado: (2011)

microRNA-503 inhibits gastric cancer cell growth and epithelial-to-mesenchymal transition
por: PENG, YANG, et al.
Publicado: (2014)

MicroRNA-153 suppresses human laryngeal squamous cell carcinoma migration and invasion by targeting the SNAI1 gene
por: Zhang, Binbin, et al.
Publicado: (2018)

Programmed Death Ligand 1 Expression in Laryngeal Squamous Cell Carcinomas and Prognosis
por: Batur, Sebnem, et al.
Publicado: (2020)

MicroRNA-4728 serves as a suppressor and antagonist of oncogenic MAPK in Burkitt lymphoma
por: Wang, Wei, et al.
Publicado: (2018)

Inhibiting MicroRNA-503 and MicroRNA-181d with Losartan Ameliorates Diabetic Nephropathy in KKAy Mice
por: Zhu, XinWang, et al.
Publicado: (2016)

MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM
por: Chong, Yang, et al.
Publicado: (2014)

MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1
por: Lin, Nengxing, et al.
Publicado: (2017)

HDAC2 enhances esophageal squamous cell carcinoma development through down-regulating microRNA-503-5p and promoting CXCL10
por: Li, Jindong, et al.
Publicado: (2021)

The Expression of MicroRNA-155 in Plasma and Tissue Is Matched in Human Laryngeal Squamous Cell Carcinoma
por: Wang, Jian-ling, et al.
Publicado: (2016)

Silencing of MicroRNA-503 in Rat Mesenchymal Stem Cells Exerts Potent Antitumorigenic Effects in Lung Cancer Cells
por: Huang, Bo, et al.
Publicado: (2021)

MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
por: Tian, Yifu, et al.
Publicado: (2018)

MicroRNA-181 serves an oncogenic role in breast cancer via the inhibition of SPRY4
por: Tian, Yifu, et al.
Publicado: (2022)

MicroRNA-424 serves an anti-oncogenic role by targeting cyclin-dependent kinase 1 in breast cancer cells
por: Xie, Dan, et al.
Publicado: (2018)

MicroRNA-31: a pivotal oncogenic factor in oral squamous cell carcinoma
por: Lin, Xiaojiao, et al.
Publicado: (2022)

MicroRNA-375 inhibits laryngeal squamous cell carcinoma progression via targeting CST1
por: Dai, Feng, et al.
Publicado: (2022)

MiR-25-3p Serves as an Oncogenic MicroRNA by Downregulating the Expression of Merlin in Osteosarcoma
por: Rao, Hua-chun, et al.
Publicado: (2020)

microRNA-503 contribute to pancreatic beta cell dysfunction by targeting the mTOR pathway in gestational diabetes mellitus
por: Xu, Ke, et al.
Publicado: (2017)

MicroRNA-503-5p improves carotid artery stenosis by inhibiting the proliferation of vascular smooth muscle cells
por: Yan, Zhiyuan, et al.
Publicado: (2020)

MicroRNA‐503 promotes angiotensin II‐induced cardiac fibrosis by targeting Apelin‐13
por: Zhou, Yuhong, et al.
Publicado: (2016)

HDAC2 interacts with microRNA-503-5p to regulate SGK1 in osteoarthritis
por: Wang, Zheng, et al.
Publicado: (2021)

MicroRNA-183 promotes proliferation and invasion in oesophageal squamous cell carcinoma by targeting programmed cell death 4
por: Ren, L-H, et al.
Publicado: (2014)

LncRNA MNX1-AS1 drives aggressive laryngeal squamous cell carcinoma progression and serves as a ceRNA to target FoxM1 by sponging microRNA-370
por: Cui, Xiangyan, et al.
Publicado: (2021)

Effect of Programmed Death-Ligand 1 in Cancer-Associated Fibroblasts on Advanced Laryngeal Squamous Cell Carcinoma
por: Yang, Zhendong, et al.
Publicado: (2021)

MicroRNA-548ac induces apoptosis in laryngeal squamous cell carcinoma cells by targeting transmembrane protein 158
por: Song, Fucun, et al.
Publicado: (2020)

MicroRNA-340-5p suppresses non-small cell lung cancer cell growth and metastasis by targeting ZNF503
por: Lu, Guojie, et al.
Publicado: (2019)

High microRNA-23a expression in laryngeal squamous cell carcinoma is associated with poor patient prognosis
por: Zhang, Xiao-Wen, et al.
Publicado: (2015)

MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8
por: Li, MingHua, et al.
Publicado: (2015)

Systematic review and meta-analysis of prognostic microRNA biomarkers for survival outcome in laryngeal squamous cell cancer
por: Huang, Yan, et al.
Publicado: (2021)

A novel microRNA panel exhibited significant potential in evaluating the progression of laryngeal squamous cell carcinoma
por: Zhang, Linshi, et al.
Publicado: (2023)

miR-128-3p serves as an oncogenic microRNA in osteosarcoma cells by downregulating ZC3H12D
por: Zhu, Maoshu, et al.
Publicado: (2021)

MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor
por: Wang, Zili, et al.
Publicado: (2017)

MicroRNA-503 suppresses cell proliferation and invasion in osteosarcoma via targeting insulin-like growth factor 1 receptor
por: Wang, Zili, et al.
Publicado: (2021)

Endothelial Apelin-FGF Link Mediated by MicroRNAs 424 and 503 is Disrupted in Pulmonary Arterial Hypertension
por: Kim, Jongmin, et al.
Publicado: (2012)

Retraction: MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM
Publicado: (2022)

MicroRNA-625 inhibits cell invasion and epithelial–mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma
por: Li, Yuan, et al.
Publicado: (2019)

MiR-26a-5p Serves as an Oncogenic MicroRNA in Non-Small Cell Lung Cancer by Targeting FAF1
por: Ye, Ming-fan, et al.
Publicado: (2020)

Serum Exosomal miR-941 as a promising Oncogenic Biomarker for Laryngeal Squamous Cell Carcinoma
por: Zhao, Qinli, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qt4v3jlv3vcu9kcaehmgb7dnr3